STAFF PROFILE
Dr Jennifer Boer
Position:
Postdoctoral Research Fellow
College / Portfolio:
School of Health and Biomedical Sciences
School / Department:
Laboratory Medicine
Phone:
99257138
Email:
jennifer.boer@rmit.edu.au
Campus:
Bundoora Campus
- Al-Hatamleh, M.,Syafirah E.A.R., E.,Boer, J.,Ferji, K.,Six, J.,Chen, X.,Elkord, E.,Plebanski, M.,Mohamud, R. (2020). Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor-An Opportunity for Cancer Treatment In: Cells, 9, 1 - 16
- Skwarczynski, M.,Zhao, G.,Boer, J.,Plebanski, M., et al, . (2020). Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines In: Science Advances, 6, 1 - 1
- Al-Hatamleh, M.,Boer, J.,Wilson, K.,Plebanski, M.,Mohamud, R.,Mustafa, M. (2020). Antioxidant-based medicinal properties of stingless bee products: Recent progress and future directions In: Biomolecules, 10, 1 - 28
- Azid, N.,Ahmad, S.,Boer, J.,Al-Hatamleh, M.,Mohammad, N.,Ashari, N.,Tan, H.,Chen, X.,Plebanski, M.,Mohamud, R. (2020). (In Press) A profile of TNFR2+ regulatory T cells and CD103+ dendritic cells in the peripheral blood of patients with asthma In: Human Immunology, , 1 - 10
- Hatmal, M.,Alshaer, W.,Al-Hatamleh, M.,Hatmal, M.,Smadi, O.,Taha, M.,Oweida, A.,Boer, J.,Mohamud, R.,Plebanski, M. (2020). Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2 In: Cells, 9, 1 - 37
- Al-Hatamleh, M.,Ahmad, S.,Boer, J.,Lim, J.,Chen, X.,Plebanski, M.,Mohamud, R. (2019). A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy In: Journal of Oncology, 2019, 1 - 13
- Kartikasari, A.,Prakash, M.,Cox, M.,Wilson, K.,Boer, J.,Cauchi, J.,Plebanski, M. (2018). Therapeutic Cancer Vaccines-T Cell Responses and Epigenetic Modulation In: Frontiers in immunology, 9, 1 - 15
- Mohamud, R.,LeMasurier, J.,Boer, J.,Sieow, J.,Rolland, J.,O'Hehir, R.,Hardy, C.,Plebanski, M. (2017). Synthetic nanoparticles that promote tumor necrosis factor receptor 2 expressing regulatory T cells in the lung and resistance to allergic airways inflammation In: Frontiers in Immunology, 8, 1 - 12